Terug
Dagbereik
€ 52,53
€ 54,24
52-Weeksbereik
€ 22,28
€ 59,55
Volume
4.423.528
50D / 200D Gem.
€ 47,06
/
€ 32,47
Vorige Slotkoers
€ 51,34
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,5 | 0,3 |
| P/B | 2,4 | 3,0 |
| ROE % | -28,9 | 3,7 |
| Net Margin % | -145,2 | 3,8 |
| Rev Growth 5Y % | -42,5 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 35,67
-33.4%
Low: € 17,00
High: € 63,00
Forward WPA
-€ 6,39
Omzet Sch.
2,08B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,66
€ 1,98 – € 4,35
|
6,67B | 6 |
| FY2029 |
-€ 0,03
-€ 0,05 – -€ 0,02
|
5,03B | 10 |
| FY2028 |
-€ 2,90
-€ 6,17 – € 0,69
|
3,16B | 15 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | -€ 2,54 | -€ 2,11 | +17,1% |
| 2025-11-06 | -€ 1,87 | -€ 0,51 | +72,7% |
| 2025-08-01 | -€ 2,99 | -€ 2,13 | +28,8% |
| 2025-05-01 | -€ 2,92 | -€ 2,52 | +13,7% |
| 2025-02-14 | -€ 2,68 | -€ 2,50 | +6,7% |
| 2024-11-07 | -€ 1,91 | € 0,03 | +101,6% |
| 2024-08-01 | -€ 3,35 | -€ 3,33 | +0,6% |
| 2024-05-02 | -€ 3,56 | -€ 3,07 | +13,8% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue declined -42,46% annually over 5 years
Debt/Equity of 0,22 — conservative balance sheet
Negative free cash flow of -2,07B
PEG of 0,19 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,23%
Capital efficient — spends only 9,88% of revenue on capex
Groei
Revenue Growth (5Y)
-42,46%
Revenue (1Y)-39,23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-28,87%
ROIC-21,82%
Net Margin-145,16%
Op. Margin-158,13%
Veiligheid
Debt / Equity
0,22
Current Ratio3,29
Interest Coverage0,00
Waardering
P/E Ratio
-7,49
Forward P/EN/A
P/B Ratio2,44
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -39,23% | Revenue Growth (3Y) | -46,72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -42,46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,94B | Net Income (TTM) | -2,82B |
| ROE | -28,87% | ROA | -22,87% |
| Gross Margin | 55,35% | Operating Margin | -158,13% |
| Net Margin | -145,16% | Free Cash Flow (TTM) | -2,07B |
| ROIC | -21,82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 3,29 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7,49 | Forward P/E | N/A |
| P/B Ratio | 2,44 | P/S Ratio | 10,88 |
| PEG Ratio | 0,19 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 10,18 | Fwd Earnings Yield | N/A |
| FCF Yield | -9,77% | ||
| Market Cap | 21,15B | Enterprise Value | 20,47B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,94B | 3,20B | 6,85B | 18,88B | 17,74B |
| Net Income | -2,82B | -3,56B | -4,71B | 8,36B | 12,20B |
| EPS (Diluted) | -7,26 | -9,27 | -12,34 | 20,10 | 28,29 |
| Gross Profit | 1,08B | 1,74B | 2,16B | 13,46B | 15,12B |
| Operating Income | -3,07B | -3,95B | -4,24B | 9,42B | 13,30B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,34B | 14,14B | 18,43B | 25,86B | 24,67B |
| Total Liabilities | 3,69B | 3,24B | 4,57B | 6,74B | 10,52B |
| Shareholders' Equity | 8,65B | 10,90B | 13,85B | 19,12B | 14,15B |
| Total Debt | 1,92B | 747,00M | 1,24B | 1,20B | 916,00M |
| Cash & Equivalents | 2,60B | 1,93B | 2,91B | 3,21B | 6,85B |
| Current Assets | 6,54B | 8,10B | 10,33B | 13,43B | 16,07B |
| Current Liabilities | 1,99B | 2,21B | 3,02B | 4,92B | 9,13B |